CIA
BSX icon

Caerus Investment Advisors’s Boston Scientific BSX Stock Holding History

Caerus Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Buy
+3,759
New +$301K 0.1% 208
2025
Q4 		– Sell
-2,532
Closed -$247K – 319
2025
Q3 		$247K Buy
+2,532
New +$262K 0.1% 232

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caerus Investment Advisors's BSX Position: Q1 2026 in Review

Caerus Investment Advisors opened a new position in Boston Scientific (BSX) in Q1 2026: 3,759 shares worth $236K. The stake represents 0.1% of the portfolio and ranks #208 among its holdings. This is a return to the name: Caerus Investment Advisors previously reported a position in BSX as recently as Q3 2025.

Caerus Investment Advisors first reported a position in BSX in Q3 2025 and has held it in 2 quarters since. The position peaked at $247K in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Caerus Investment Advisors held 3,759 shares of Boston Scientific worth $236K as of Q1 2026.
  • Boston Scientific was a new Caerus Investment Advisors position in Q1 2026.
  • Boston Scientific made up 0.1% of Caerus Investment Advisors's portfolio in Q1 2026, its #208 holding.
  • Caerus Investment Advisors first reported a position in Boston Scientific in Q3 2025 and has held it in 2 quarters since.
  • Caerus Investment Advisors's Boston Scientific position peaked at $247K in Q3 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Caerus Investment Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.